Clinical Trials Directory

Trials / Unknown

UnknownNCT04508712

Long-term Outcomes in Patients With COVID-19

Status
Unknown
Phase
Study type
Observational
Enrollment
900 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Long-term outcomes from coronavirus disease 2019 (COVID-19) are currently unknown. This study will collect daily living status of survivors of COVID-19.

Detailed description

The ongoing pandemic of coronavirus disease 2019 (COVID-19), due to the newly discovered severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2), has caused a worldwide increase in hospitalization for pneumonia with multi- organ disease. Survival from sepsis is associated with increased risk for mortality for at least 2 years. Therefore, substantial sequelae including new physical disability, new cognitive impairment and increased vulnerability to further health deterioration are likely to be seen in survivors of COVID-19. The investigators conduct this study to investigate daily living status of survivors of COVID-19 using telephone interview questionnaire including Activity Daily Living(ADL), modified Medical Research Council(mMRC),modified Telephone Interview for Cognitive Status (TICS-m), Zung Self-rating Depression Scale(SDS), Carcinologic Handicap Index (CHI), and New York Heart Association (NYHA) functional class.

Conditions

Timeline

Start date
2020-08-10
Primary completion
2021-08-31
Completion
2021-08-31
First posted
2020-08-11
Last updated
2020-10-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04508712. Inclusion in this directory is not an endorsement.

Long-term Outcomes in Patients With COVID-19 (NCT04508712) · Clinical Trials Directory